Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2008 1
2009 1
2010 1
2014 3
2015 8
2016 7
2017 4
2018 9
2019 23
2020 20
2021 14
2022 15
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
Appendiceal Mucinous Neoplasms: Diagnosis and Management.
Shaib WL, Assi R, Shamseddine A, Alese OB, Staley C 3rd, Memis B, Adsay V, Bekaii-Saab T, El-Rayes BF. Shaib WL, et al. Among authors: alese ob. Oncologist. 2017 Sep;22(9):1107-1116. doi: 10.1634/theoncologist.2017-0081. Epub 2017 Jun 29. Oncologist. 2017. PMID: 28663356 Free PMC article. Review.
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.
Llovet JM, Kudo M, Merle P, Meyer T, Qin S, Ikeda M, Xu R, Edeline J, Ryoo BY, Ren Z, Masi G, Kwiatkowski M, Lim HY, Kim JH, Breder V, Kumada H, Cheng AL, Galle PR, Kaneko S, Wang A, Mody K, Dutcus C, Dubrovsky L, Siegel AB, Finn RS; LEAP-002 Investigators. Llovet JM, et al. Lancet Oncol. 2023 Dec;24(12):1399-1410. doi: 10.1016/S1470-2045(23)00469-2. Lancet Oncol. 2023. PMID: 38039993 Clinical Trial.
Phase II trial of nivolumab and metformin in patients with treatment-refractory microsatellite stable metastatic colorectal cancer.
Akce M, Farran B, Switchenko JM, Rupji M, Kang S, Khalil L, Ruggieri-Joyce A, Olson B, Shaib WL, Wu C, Alese OB, Diab M, Lesinski GB, El-Rayes BF. Akce M, et al. Among authors: alese ob. J Immunother Cancer. 2023 Oct;11(10):e007235. doi: 10.1136/jitc-2023-007235. J Immunother Cancer. 2023. PMID: 37852737 Free PMC article. Clinical Trial.
Update on Emerging Therapies for Advanced Colorectal Cancer.
Alese OB, Wu C, Chapin WJ, Ulanja MB, Zheng-Lin B, Amankwah M, Eads J. Alese OB, et al. Am Soc Clin Oncol Educ Book. 2023 May;43:e389574. doi: 10.1200/EDBK_389574. Am Soc Clin Oncol Educ Book. 2023. PMID: 37155942 Free article.
Aquaporins: Their role in gastrointestinal malignancies.
Nagaraju GP, Basha R, Rajitha B, Alese OB, Alam A, Pattnaik S, El-Rayes B. Nagaraju GP, et al. Among authors: alese ob. Cancer Lett. 2016 Apr 1;373(1):12-18. doi: 10.1016/j.canlet.2016.01.003. Epub 2016 Jan 15. Cancer Lett. 2016. PMID: 26780474 Review.
Cancer healthcare disparities among African Americans in the United States.
Mitchell E, Alese OB, Yates C, Rivers BM, Blackstock W, Newman L, Davis M, Byrd G, Harris AE. Mitchell E, et al. Among authors: alese ob. J Natl Med Assoc. 2022 Jun;114(3):236-250. doi: 10.1016/j.jnma.2022.01.004. Epub 2022 Mar 21. J Natl Med Assoc. 2022. PMID: 35321808 Review.
106 results